Qudexy XR

topiramate extended-release · Upsher-Smith Laboratories

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Qudexy XR, covering 2016-06-02 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old [Phase 4]